India-EU trade deal under the looming shadow of Donald Trump

India and the EU reached a landmark trade agreement that would deepen ties between the bloc and India — the EU was India’s largest goods partner at $142.3bn in 2024 (11.5% of India’s trade) — but the pact still requires lengthy legal finalisation and ratification. The deal is driven in part by geopolitical hedging against unpredictable US tariff threats (including recent US tariffs and threats linked to Indian purchases of Russian oil) and aims to diversify supply chains and defence procurement away from traditional partners; key outstanding issues include intellectual property, agriculture and carbon rules and possible legal hurdles similar to the Mercosur saga.

Analysis

Market structure: The India–EU FTA is a win for export-heavy Indian sectors (textiles, gems, pharmaceuticals, IT services) and EU capital goods, aerospace/defence and luxury goods — expect incremental market-share shifts from China to India in labour‑intensive and pharma supply chains over 12–36 months. Pricing power will tilt toward Indian exporters (higher volumes) and specialised European suppliers (defence, high-end manufacturing); shipping and logistics capacity serving India–EU lanes should see utilisation lift, pressuring container rates upward episodically.

Risk assessment: Tail risks include US retaliatory tariffs or secondary sanctions (low probability but severe — >25–100% tariffs would shock flows) and EU ratification failure (10–30% chance within 12 months). Immediate (days) volatility likely muted; short term (3–12 months) is governed by legal text finalisation and parliament votes; long term (2–5 years) is supply‑chain realignment benefitting capex and raw-material demand. Hidden dependencies: India’s continued Russian oil imports keep US leverage alive and can trigger secondary actions.

Trade implications: Tactical long India exposure (equity ETFs, selective large caps) vs short China exporters is attractive: relative-value should play out over 6–24 months as sourcing shifts. Fixed income/currency: anticipate gradual INR strength vs USD/EUR over 12–36 months — favour long INR exposure via forwards or INR‑linked debt. Commodities: overweight industrial metals (copper, steel inputs) as Indian manufacturing ramps.

Contrarian angles: Consensus underprices ratification risk and US political tail-risk; markets may underreact to near-term regulatory drag while overpricing long-term seamless re-shoring. A mispriced outcome: Indian equity rerating could be underdone (look for 10–25% upside vs China if ratification proceeds), but if US imposes broad tariffs the opposite could unwind quickly.

Key Decisions for Investors

• Establish a 2–3% portfolio long position in INDA (iShares MSCI India ETF) over next 4–12 weeks, add on >5% pullback; target 12–24 month horizon, take profit on 15–25% gains or if EU parliament signals definitive ratification.
• Pair trade: Long INFY (Infosys, 1% portfolio) and short FXI (iShares China Large‑Cap ETF, 1% portfolio) to express India‑over‑China reallocation; rebalance after 6 months or if FXI outperforms by >10% vs INDA.
• Buy 9–12 month call options on INDA (size ~0.5–1% of portfolio in premiums) to lever upside while limiting downside; alternatively use a call spread to cap premium if IV>25%.
• Overweight industrial‑metals miners BHP (1% portfolio) and FCX (1% portfolio) for 12–36 months to capture higher input demand if EU–India supply‑chain shift accelerates; sell into a 20% rally.
• Short USD/INR forward (or buy INR forwards) sized to 1–2% FX exposure for clients with currency capability, target USD/INR drop of 3–7% over 12–24 months; unwind if INR weakens >5% from entry or if US imposes tariffs affecting trade flows.